Nombre del producto:3-(2-bromo-7-oxo-4,5-dihydrofuro[2,3-c]pyridin-6-yl)piperidine-2,6-dione

IUPAC Name:3-{2-bromo-7-oxo-4H,5H,6H,7H-furo[2,3-c]pyridin-6-yl}piperidine-2,6-dione

CAS:2970215-73-5
Fórmula molecular:C12H11BrN2O4
Pureza:97%
Número de catálogo:CM1076099
Peso molecular:327.13

Unidad de embalaje Stock disponible Precio($) Cantidad
CM1076099-100mg in stock ȤŸdž
CM1076099-250mg in stock ƩȋǺŸ
CM1076099-500mg in stock ǺǺƩœ
CM1076099-1g in stock ȋȋǺȋ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2970215-73-5
Fórmula molecular:C12H11BrN2O4
Punto de fusión:-
Código de sonrisas:BrC1=CC2=C(O1)C(=O)N(CC2)C1CCC(=O)NC1=O
Densidad:
Número de catálogo:CM1076099
Peso molecular:327.13
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.

Related Products